MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 120 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $172,000 | -55.9% | 132,610 | +4.2% | 0.00% | -100.0% |
Q1 2017 | $390,000 | -37.4% | 127,300 | -16.6% | 0.00% | 0.0% |
Q4 2016 | $623,000 | +7.8% | 152,722 | +65.5% | 0.00% | -33.3% |
Q3 2016 | $578,000 | +214.1% | 92,300 | +181.4% | 0.00% | +200.0% |
Q2 2016 | $184,000 | – | 32,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
Birchview Capital, LP | 44,000 | $136,000 | 0.08% |